Kristin Hung, MD
Obstetrics & Gynecology · Boston, MANPI 1285945022
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Boston Scientific at 31.8% of the total. Reporting peaked in 2021 at $812 and has fallen 53.0% since, to $381 in 2025. Among obstetrics & gynecology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 15 payments — averaging $173.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$827
- Medtronic$759
- C. R. Bard, Inc. & Subsidiaries$310
- Axonics, Inc.$267
- Bard Access Systems, Inc.$256
- Caldera Medical, Inc$185
What the payments were for
- Consulting fees$1,16645%
- Travel & lodging$351%
- Food & beverage$1,40354%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 8 | $827 |
| Medtronic | 2 | $759 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $310 |
| Axonics, Inc. | 2 | $267 |
| Bard Access Systems, Inc. | 1 | $256 |
| Caldera Medical, Inc | 1 | $185 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,604 in reported general payments places this provider in the 90th percentile of 910 obstetrics & gynecology providers in Massachusetts.
See all obstetrics & gynecology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 183 | $151,289 |
| MyrbetriqMirabegron | 42 | $16,665 |
| Estradiol | 182 | $13,266 |
| Methenamine Hippurate | 49 | $4,039 |
| Mirabegron ErMirabegron | 13 | $3,368 |
| YuvafemEstradiol | 20 | $2,299 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 42 | $391 |
| Ibuprofen | 41 | $117 |
| Oxycodone Hcl | 39 | $59 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Boston
- Elizabeth OnyemelukweBoston$135K
- James GreenbergBoston$119K
- Stephanie AlimenaBoston$75K
- Denis VaughanBoston$38K
- Roxanne GardnerBoston$31K
- Marc LauferBoston$23K
- Michelle LightfootBoston$23K
- Paul HendessiBoston$18K
- Marcus OrtegaBoston$17K
- Elizabeth GagliardiBoston$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.